Novavax Inc (NVAX)

$8.52 +0.16 (1.91%)
Market Cap 1.36B
Revenue (ttm) 682.16M
Net Income (ttm) -187.50M
EPS (ttm) N/A
PE Ratio 3.71
Forward PE 3.31
Profit Margin -27.49%
Debt to Equity Ratio 0.00
Volume 2,759,500
Avg Vol 5,571,884
Day's Range N/A - N/A
Shares Out 162.42M
Stochastic %K 38%
Beta 2.74
Analysts Sell
Price Target $12.50

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 268 2000
Address:
700 Quince Orchard Road, Gaithersburg, United States
Benroxx
Benroxx Oct. 25 at 4:50 PM
$NVAX We want fair share price now
0 · Reply
Benroxx
Benroxx Oct. 25 at 4:49 PM
$NVAX
0 · Reply
novavaxfan
novavaxfan Oct. 25 at 3:46 PM
$NVAX If Sanofi can sell Nuvaxoid to 3 million people the revenue would 505.05 million. NVAX would receive, approximately 100 million in Royalties. I had to replace a toilet in my bathroom, I bought the very best toilet which cost more than any other one. NVAX has the best vaccine which has the highest price.
0 · Reply
west281356
west281356 Oct. 25 at 3:26 PM
$NVAX Around the 43 minute mark, Dr. Griffen indicates that his mother-in-law took the Novavax shot specifically rather than the mRNA. https://podcasts.apple.com/us/podcast/this-week-in-virology/id300973784?i=1000733421227
0 · Reply
buhuo8888
buhuo8888 Oct. 25 at 3:21 PM
$NVAX It still tastes very bitter to me that why most people are so adamant about keeping 6ft between each other during the Covid years, yet DO NOT do any research, any self education, any due diligence, and frankly don't seem to care any bit, of what was/is being injected into their bodies..... even TODAY after 5 years, and how many those poison shots + how many times of infection already!!!
2 · Reply
Leon_32
Leon_32 Oct. 25 at 3:12 PM
$NVAX $XBI $SPY very nice video about how big short works
0 · Reply
Paulchowda
Paulchowda Oct. 25 at 3:10 PM
$NVAX happy glorious Saturday from windy Florida, Andy should be proud and I think there’s a couple other guys on our team here responsible for that. I’ve been in touch with one gentleman texting back-and-forth, it just so happens his best friend lives on my street here small world, but anyway, I blocked that guy who said it was wrong. It’s not the shorting yada yada, still on island time, but I’m gonna watch it a couple more times, and very impressed by it. Hell yeah.GO NVAX !
1 · Reply
nikeita
nikeita Oct. 25 at 2:40 PM
$NVAX So the question is: if everything revolves around the convertibles, why carry out yet another restructuring using the same tool? I don’t believe the company was unaware of the negative impact caused by C-Bonds and the consequences of a further increase in shorted shares. So, what kind of value increase for shareholders are they referring to?
2 · Reply
zulutrix
zulutrix Oct. 25 at 2:32 PM
$NVAX more and more I educate myself about C bonds, it makes me furious what JJ did by refinancing rather than paying it off. He handed tools for HFs to short the hell out. Don't know if he is inefficient or getting some unknown benefit out of this action. There is no way to prove it. He himself doesn't even care about his reputation?
1 · Reply
REDLINE70
REDLINE70 Oct. 25 at 1:41 PM
$NVAX I watched the video Andy made. It's well done but mainly wrong in my opinion. NVAX issue is sales not shorts. The run up was due to potential vaccine sales. They have very low sales and thus SP is in the shitter. It is correct about bonds but I don't see why anything over 11.50 is going to happen without sales showing market gain or BO.
3 · Reply
Latest News on NVAX
Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Oct 22, 2025, 7:00 AM EDT - 3 days ago

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Oct 14, 2025, 1:08 PM EDT - 11 days ago

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Oct 14, 2025, 6:09 AM EDT - 11 days ago

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Oct 7, 2025, 7:00 AM EDT - 18 days ago

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Novavax Announces Progress on Sanofi Agreement

Sep 30, 2025, 9:01 AM EDT - 25 days ago

Novavax Announces Progress on Sanofi Agreement

Mizuho's Jared Holz: There's not much value left in vaccine stocks

Sep 19, 2025, 11:40 AM EDT - 5 weeks ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

BNTX MRNA PFE

Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 2:10 PM EDT - 7 weeks ago

Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Sep 4, 2025, 8:00 AM EDT - 7 weeks ago

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Novavax to Participate in the Cantor Global Healthcare Conference

Sep 3, 2025, 8:00 AM EDT - 7 weeks ago

Novavax to Participate in the Cantor Global Healthcare Conference

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Aug 27, 2025, 3:07 PM EDT - 2 months ago

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Novavax Announces Convertible Debt Refinancing

Aug 21, 2025, 7:43 AM EDT - 2 months ago

Novavax Announces Convertible Debt Refinancing

Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 3:56 PM EDT - 2 months ago

Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript

Novavax beats quarterly revenue estimates on milestone payment

Aug 6, 2025, 8:08 AM EDT - 2 months ago

Novavax beats quarterly revenue estimates on milestone payment

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Aug 6, 2025, 8:00 AM EDT - 2 months ago

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 30, 2025, 8:00 AM EDT - 3 months ago

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Jul 24, 2025, 11:02 AM EDT - 3 months ago

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Jul 24, 2025, 8:00 AM EDT - 3 months ago

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Jun 11, 2025, 8:59 PM EDT - 4 months ago

Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Jun 11, 2025, 7:11 AM EDT - 4 months ago

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Jun 11, 2025, 7:00 AM EDT - 4 months ago

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Vaccine actions and policy positions under US Health Secretary Kennedy

Jun 10, 2025, 10:45 AM EDT - 4 months ago

Vaccine actions and policy positions under US Health Secretary Kennedy

BNTX MRNA PFE

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

Jun 10, 2025, 9:30 AM EDT - 4 months ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

BNTX MRNA PFE

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

Jun 10, 2025, 8:18 AM EDT - 4 months ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

BNTX MRNA PFE SNY

Novavax to Participate in Upcoming Investor Conferences

May 29, 2025, 8:00 AM EDT - 5 months ago

Novavax to Participate in Upcoming Investor Conferences

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

May 21, 2025, 8:15 AM EDT - 5 months ago

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

May 20, 2025, 4:34 PM EDT - 5 months ago

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

May 19, 2025, 12:15 PM EDT - 5 months ago

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

AZO TSLA

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

May 19, 2025, 9:27 AM EDT - 5 months ago

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

May 19, 2025, 7:16 AM EDT - 5 months ago

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

May 19, 2025, 7:00 AM EDT - 5 months ago

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

FDA approves Novavax COVID vaccine with new conditions

May 17, 2025, 10:26 PM EDT - 5 months ago

FDA approves Novavax COVID vaccine with new conditions

Novavax, Inc. (NVAX) Presents at BofA Securities 2025 Health Care Conference (Transcript)

May 14, 2025, 10:46 PM EDT - 5 months ago

Novavax, Inc. (NVAX) Presents at BofA Securities 2025 Health Care Conference (Transcript)

Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat

May 12, 2025, 12:45 PM EDT - 5 months ago

Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

May 8, 2025, 1:31 PM EDT - 6 months ago

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

Novavax, Inc. (NVAX) Q1 2025 Earnings Call Transcript

May 8, 2025, 11:48 AM EDT - 6 months ago

Novavax, Inc. (NVAX) Q1 2025 Earnings Call Transcript

Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

May 8, 2025, 11:12 AM EDT - 6 months ago

Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

Novavax swings to profit on lower expenses related to COVID shots

May 8, 2025, 8:06 AM EDT - 6 months ago

Novavax swings to profit on lower expenses related to COVID shots

Novavax Reports First Quarter 2025 Financial Results and Operational Highlights

May 8, 2025, 8:00 AM EDT - 6 months ago

Novavax Reports First Quarter 2025 Financial Results and Operational Highlights

New vaccine chief rocks pharmaceutical stocks

May 7, 2025, 11:13 AM EDT - 6 months ago

New vaccine chief rocks pharmaceutical stocks

BNTX MRNA PFE GSK IBB SRPT XBI

Novavax to Participate in BofA Securities 2025 Health Care Conference

May 7, 2025, 8:00 AM EDT - 6 months ago

Novavax to Participate in BofA Securities 2025 Health Care Conference

Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan

May 5, 2025, 8:00 AM EDT - 6 months ago

Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan

Novavax to Report First Quarter 2025 Financial Results on May 8, 2025

May 1, 2025, 8:00 AM EDT - 6 months ago

Novavax to Report First Quarter 2025 Financial Results on May 8, 2025

Novavax Appoints Charles Newton to Board of Directors

Apr 29, 2025, 8:00 AM EDT - 6 months ago

Novavax Appoints Charles Newton to Board of Directors

FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports

Apr 25, 2025, 3:35 PM EDT - 6 months ago

FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports

FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot

Apr 25, 2025, 3:20 PM EDT - 6 months ago

FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot

Insight: As FDA delays Novavax' COVID vaccine approval, patients fight back

Apr 24, 2025, 6:04 AM EDT - 6 months ago

Insight: As FDA delays Novavax' COVID vaccine approval, patients fight back

Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps

Apr 23, 2025, 5:00 PM EDT - 6 months ago

Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps

FDA asks Novavax for commitment on post-approval studies for COVID vaccine

Apr 23, 2025, 8:26 AM EDT - 6 months ago

FDA asks Novavax for commitment on post-approval studies for COVID vaccine

SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA

Apr 15, 2025, 7:00 AM EDT - 6 months ago

SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA

Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacy

Apr 10, 2025, 3:02 PM EDT - 7 months ago

Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacy

Benroxx
Benroxx Oct. 25 at 4:50 PM
$NVAX We want fair share price now
0 · Reply
Benroxx
Benroxx Oct. 25 at 4:49 PM
$NVAX
0 · Reply
novavaxfan
novavaxfan Oct. 25 at 3:46 PM
$NVAX If Sanofi can sell Nuvaxoid to 3 million people the revenue would 505.05 million. NVAX would receive, approximately 100 million in Royalties. I had to replace a toilet in my bathroom, I bought the very best toilet which cost more than any other one. NVAX has the best vaccine which has the highest price.
0 · Reply
west281356
west281356 Oct. 25 at 3:26 PM
$NVAX Around the 43 minute mark, Dr. Griffen indicates that his mother-in-law took the Novavax shot specifically rather than the mRNA. https://podcasts.apple.com/us/podcast/this-week-in-virology/id300973784?i=1000733421227
0 · Reply
buhuo8888
buhuo8888 Oct. 25 at 3:21 PM
$NVAX It still tastes very bitter to me that why most people are so adamant about keeping 6ft between each other during the Covid years, yet DO NOT do any research, any self education, any due diligence, and frankly don't seem to care any bit, of what was/is being injected into their bodies..... even TODAY after 5 years, and how many those poison shots + how many times of infection already!!!
2 · Reply
Leon_32
Leon_32 Oct. 25 at 3:12 PM
$NVAX $XBI $SPY very nice video about how big short works
0 · Reply
Paulchowda
Paulchowda Oct. 25 at 3:10 PM
$NVAX happy glorious Saturday from windy Florida, Andy should be proud and I think there’s a couple other guys on our team here responsible for that. I’ve been in touch with one gentleman texting back-and-forth, it just so happens his best friend lives on my street here small world, but anyway, I blocked that guy who said it was wrong. It’s not the shorting yada yada, still on island time, but I’m gonna watch it a couple more times, and very impressed by it. Hell yeah.GO NVAX !
1 · Reply
nikeita
nikeita Oct. 25 at 2:40 PM
$NVAX So the question is: if everything revolves around the convertibles, why carry out yet another restructuring using the same tool? I don’t believe the company was unaware of the negative impact caused by C-Bonds and the consequences of a further increase in shorted shares. So, what kind of value increase for shareholders are they referring to?
2 · Reply
zulutrix
zulutrix Oct. 25 at 2:32 PM
$NVAX more and more I educate myself about C bonds, it makes me furious what JJ did by refinancing rather than paying it off. He handed tools for HFs to short the hell out. Don't know if he is inefficient or getting some unknown benefit out of this action. There is no way to prove it. He himself doesn't even care about his reputation?
1 · Reply
REDLINE70
REDLINE70 Oct. 25 at 1:41 PM
$NVAX I watched the video Andy made. It's well done but mainly wrong in my opinion. NVAX issue is sales not shorts. The run up was due to potential vaccine sales. They have very low sales and thus SP is in the shitter. It is correct about bonds but I don't see why anything over 11.50 is going to happen without sales showing market gain or BO.
3 · Reply
OneDollarBob
OneDollarBob Oct. 25 at 12:17 PM
$BUZZ $BYND $GME $MEME $NVAX
0 · Reply
OneDollarBob
OneDollarBob Oct. 25 at 12:17 PM
$BUZZ $BYND $GME $MEME $NVAX
1 · Reply
DragonTiger
DragonTiger Oct. 25 at 11:57 AM
$NVAX Might someone who has the contact please forward this video clip to motherfvcker ass JJ & team who are source of confidence for those Wall Street big shorts https://x.com/the43rdcaptain/status/1981828045620031728?s=46
0 · Reply
DavidT305
DavidT305 Oct. 25 at 11:52 AM
$NVAX it looks the way that sanofi deal is structured is the overhang on this. They likely sell below $150 million in Covid vaccine this yr, nvax will get below $30 million in royalties. A big covid wave might be the only hope, not likely to happen
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 11:41 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $NVAX Current Share Price: $8.52 Contracts: $NVAX January 15, 2027 $10 Calls Scale in: $2.46- $3.01 Scale out: $3.83-$4.93 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
Leon_32
Leon_32 Oct. 25 at 9:34 AM
$NVAX $TRAW $XBI $SPY https://www.birdflustocks.com 📍Novavax is listed on this website for his protein based vaccine against H5N1 📍Traws Pharma is listed for his antiviral against H5N1 (CMO is former CDC President Robert R. Redfield) https://www.birdflustocks.com
1 · Reply
Bodu
Bodu Oct. 25 at 9:30 AM
$NVAX Payments for combination vaccine that includes Novavax covid $350M plus royalties 10% See below. The royalties average 10% was told by CFO Kelly last EC.
0 · Reply
fernao
fernao Oct. 25 at 9:27 AM
$NVAX Explotion of H5N1 in Germany! Will the next mutation of this virus trigger the SP of our NVAX? What do you all think about this? The next rise of our NVAX is about to happen...
0 · Reply
buhuo8888
buhuo8888 Oct. 25 at 9:17 AM
$NVAX I watched this well done video with my wife who doesn't trade stocks, after explaining convertible bond, HF, max pain, what is legal what's not. She asked 2 questions: 1. Why SEC doesn't get involved and stop the illegal part? (fake orders and cancellation, pinning, etc.) 2. How can we (the company, the longs) break their control/manipulation? I gave her a lame response like NVAX is a very small biotech that SEC focuses on big fishes....Can anyone, anyone, chime in with a better response? Honestly, I want to know why to these two questions too.
0 · Reply
Bodu
Bodu Oct. 25 at 8:17 AM
$NVAX I”m satisfied from the Sanofi EC. 1. Within 2 weeks of September ( 15 -30 Sept ) they delivered hundreds of thousands shots. Not the idiotic 7000 shots claimed by Shah capital. 2. Phase 1-2 of the CIC covid plus Flu by Sanofi gave positive results that allow them to proceed. Remember each of these, if approved , worth $200 million cash upfront to Novavax. Plus 10% royalties. 3. No buyout by Sanofi. I see it as positive sign. Novavax is still in search for a partner which is the preferred option. Astra Zeneca, Pfizer, Merck.
4 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 7:50 AM
Enter: $NVAX Calls Strike Price: $9 Expiry Date: NOV 14 2025 Buy in Price: $0.72 - $2.08 Sell Price: $1.39 Profit : +93% (Turn every $1 into $1.93) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
ShortTrapSignal
ShortTrapSignal Oct. 25 at 7:47 AM
$BUZZ $BYND $GME $MEME $NVAX $BYND Has 0.05 Days to Cover for the shorts. That's extremely low. Which means the daily volume is extremely high, shorts simply have no issues covering their positions if any catalyst comes around. 0.05 days, that's 1/20 of the trading day which is required to cover. Almost zero deterrence for the shorts. They are going to short $BYND all the way to the OTC markets. Pink sheets, that'll be all for BEYOND MEAT going forward.
1 · Reply